What is SpineZone?
SpineZone has developed a comprehensive, personalized, non-operative treatment approach that integrates digital technology with direct onsite care. Their methodology involves a thorough evaluation of various factors contributing to pain and well-being, including pain levels, core strength, posture, weight management, diet-related inflammation, and emotional stress. Established in 2005 and headquartered in San Diego, California, SpineZone aims to provide a holistic solution for individuals seeking to manage and improve their physical health through a data-driven and personalized treatment plan.
How much funding has SpineZone raised?
SpineZone has raised a total of $12.3M across 2 funding rounds:
Debt
$350K
Series A
$12M
Debt (2020): $350K with participation from PPP
Series A (2021): $12M led by Martin Ventures, Providence Ventures, and Polaris Partners
Key Investors in SpineZone
Martin Ventures
Martin Ventures is a venture capital firm specializing in innovative healthcare companies, with a focus on transforming the healthcare ecosystem to reward providers for achieving excellent health outcomes. They actively partner with primary care practices and health systems to facilitate the transition from fee-for-service to value-based care.
Providence Ventures
Allumia Ventures, formerly known as Providence Ventures, operates in Seattle, WA and Menlo Park, CA, providing venture capital services to startups and businesses seeking investment to grow and innovate. They aim to support entrepreneurs in achieving their goals through strategic funding.
Polaris Partners
Polaris Partners is a venture capital firm that specializes in backing transformational companies in the biotech and healthcare sectors, partnering with entrepreneurs to create successful business solutions and providing resources for growth.
What's next for SpineZone?
The recent major strategic investment signifies a pivotal moment for SpineZone, indicating a strong market validation and providing the necessary capital for scaling its innovative treatment model. This Series A financing is expected to fuel further development of their digital platforms, expansion of onsite care facilities, and enhancement of their personalized treatment protocols. The company is well-positioned to capitalize on the growing demand for non-invasive, technology-enabled healthcare solutions, potentially solidifying its market leadership in personalized pain management and rehabilitation.
See full SpineZone company page
